Core Viewpoint - The company, Yimai Sunshine Group, is positioned as a leader in the medical imaging sector under China's "Healthy China" strategy, benefiting from policy support and focusing on both economic efficiency and social responsibility [2][5]. Group 1: Economic Efficiency and Innovation - Yimai Sunshine has redefined the development path of third-party medical imaging centers in China through a "shared model," establishing a strong competitive moat [2]. - The company is experiencing rapid growth, with revenue and profit entering a synchronized leap phase [2]. - Yimai Sunshine leverages AI technology to create a unique technical system with independent intellectual property rights, enhancing its competitive advantage [3]. - The AI medical imaging market in China is projected to reach 6.17 billion yuan by 2025 and 13.74 billion yuan by 2030 [3]. - The company has made significant strides in medical data assetization, ensuring data accuracy and security, and promoting the marketization of medical imaging data [3][4]. Group 2: Social Value and Healthcare Improvement - Yimai Sunshine aims to address the imbalance in medical resource distribution in China, focusing on empowering both patients and healthcare institutions [7]. - The company has established over 100 imaging centers nationwide, serving more than 500 institutions and achieving an annual scanning volume of over 10 million [7]. - By providing comprehensive support to partner hospitals, Yimai Sunshine enhances their diagnostic capabilities and operational efficiency [7][8]. - The company employs a dual-driven model, focusing on both patient services and empowering medical institutions, which has proven effective in maintaining long-term partnerships [7][8]. Group 3: International Expansion - Yimai Sunshine is expanding its international presence by leveraging cost advantages in hardware, labor, and data services [9]. - The company aims to replace low-experience local information systems overseas with its established cloud and AI platforms, enhancing the quality of medical services internationally [9].